Active Ingredient(s): Alemtuzumab
FDA Approved: * May 7, 2001
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Campath Overview

Alemtuzumab, sold under the brand names Campath and Lemtrada among others, is a medication used to treat chronic lymphocytic leukemia (CLL) and multiple sclerosis.[1] In CLL, it has been used as both a first line and second line treatment.[1] In MS it is generally only recommended if other treatments have not worked.[1] It is given by injection into a vein.[1] It is a monoclonal antibody that binds to CD52, a protein present on t...

Read more Campath Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Campath Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 10mg/ml, 12mg/1.2ml (10mg/ml), 30mg/ml
  • Vial: 10mg/ml, 30mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Campath: (1 result)

Sorted by National Drug Code
  • 58468-0357 Campath 30 mg/ml Intravenous Injection by Genzyme Corporation

Other drugs which contain Alemtuzumab or a similar ingredient: (1 result)